Robert Miller appointed Chief Executive Officer of Wellbeing Software
LONDON, March 7, 2022 /PRNewswire/ -- Wellbeing Software, a UK market leader in connected healthcare software, is pleased to announce that Robert Miller has been appointed as Chief Executive Officer. Robert begins his role at Wellbeing on March 7. Robert brings a proven track record of more than 30 years scaling health software companies both in the UK and...
TCI Enters into Strategic Alliance with VeCollal(R) and CDMO the World’s First, Science-based vegan collagen alternative
TAIPEI, March 7, 2022 /PRNewswire/ -- Today TCI (8436TT) announced its strategic alliance with VeCollal® , the well-known Belgium based vegan collagen alternative company which has joined hands with TCI. The VeCollal® vegan collagen alternative has been designed to have the identical amino acid profile as Type I human collagen and through an in-vitro experiment, doubled the collagen secretion....
Keymed has been included as eligible stocks of the Shenzhen-Hong Kong Stock Connect
CHENGDU, China, March 7, 2022 /PRNewswire/ -- Keymed Biosciences Inc. (2162.HK) is pleased to announce that the shares of the Company have been included as eligible stocks of the Shenzhen-Hong Kong Stock Connect with effect from March 7, 2022, pursuant to the announcement issued by the Shenzhen Stock Exchange. This means that domestic investors who meet the relevant eligibility...
Academic Stress and Emotional Well-Being in Students with Colour Vision Deficiency
KUALA LUMPUR, Malaysia, March 7, 2022 /PRNewswire/ -- Head of Optometry and Vision Science Programme from the Faculty of Health Sciences, Universiti Kebangsaan Malaysia (UKM), Prof Dr Sharanjeet Kaur Malkeet Singh found that students with congenital colour vision deficiency have emotional problems and poor academic performance, affecting their quality of life in a long run. ...
HCmed, Formosa Laboratories, and Formosa Pharmaceuticals Signed MoU to Form a Global CDMO for Inhalation Treatment Drugs
TAIPEI, March 7, 2022 /PRNewswire/ -- HCmed Innovations, Co., Ltd. (HCmed) announced that it has formed a strategic alliance with Formosa Laboratories, Inc. (TPEx: 4746) and Formosa Pharmaceuticals, Inc. (TPEx: 6838) to expand its business in the inhalation treatment field, providing contract development and manufacturing services. By integrating HCmed's vibrating mesh nebulizers, Formosa Laboratories' drug development and manufacturing capabilities,...
AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer
GUANGZHOU, China, March 7, 2022 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announce that Dr. Marina Bibikova has come on board as Chief Scientific Officer (CSO). She will be responsible for cancer early detection technology development, global IVD registrations, strategic partnerships with leading overseas companies,...
Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of KX-826 in China for the Treatment of Androgenetic Alopecia in Female Patients
SUZHOU, China, March 7, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced that the company has completed the enrollment of 160 patients for its phase II clinical trial of KX-826 ("pyrilutamide") in China for the treatment of female androgenetic alopecia (AGA) on 4 March 2022, which has...
New Robotic Assisted Transperineal Needle-Guidance System for Prostate Biopsy and Cancer Ablations Received U.S FDA 510(k) Clearance
SINGAPORE, March 5, 2022 /PRNewswire/ -- Biobot Surgical is excited to announce U.S. FDA 510(k) clearance of the iSR'obot Mona Lisa 2.0. The new robotic assisted transperineal needle-guidance system allows urologists to plan and position a single needle or multiple needles during image-guided diagnostic and interventional prostate procedures. The iSR'obot Mona Lisa 2.0 is the latest addition to Biobot Surgical's...
China.org.cn: Hong Kong’s fight against COVID-19: a test for “one country, two systems”
BEIJING, March 4, 2022 /PRNewswire/ -- A news report from China.org.cn on Hong Kong's COVID-19 pandemic situation:   Hong Kong has been taken aback by the 5th onset of the COVID-19 pandemic, and it's spreading fast. Hong Kong is a metropolis that runs under the "one country, two systems" principle, serving as a bridge that connects China...
Aravax Pty Ltd announces opening of IND for Phase 2 clinical trials of PVX108, a next-generation immunotherapy for the treatment of peanut allergy
Phase 2 study of PVX108 to commence in United States and Australia Dr Robert A. Wood, professor of pediatrics at the Johns Hopkins University School of Medicine, joins Scientific Advisory Board MELBOURNE, Australia, March 4, 2022 /PRNewswire/ -- Aravax, a clinical stage biotechnology company focused on developing the first therapy for peanut allergy which is designed to...
